Treatment of HIV in Israel - Effective Treatment of AIDS Abroad

HIV treatment in Israel can guarantee that a person with HIV can live normally. Anti-HIV drugs work by reducing the amount of HIV in the blood, viral load. The goal of HIV treatment is viral load. This means that after HIV treatment abroad, the amount of HIV in the blood is so small that it can not be detected by standard tests. Reducing the amount of HIV in the blood can strengthen the immune system. The higher the level of CD4 cells, the lower the risk of getting sick due to HIV infection and, possibly, from some other serious diseases.

You should discuss with your doctor the best time for you to start treatment for HIV abroad. There are a number of factors that you can consider, including: The benefits of starting treatment now. Potential risks if there is a delay in starting treatment. Are you ready to start treatment now? There are other factors in your life that affect the ability and need to start AIDS treatment in Israel.

In most cases, a full course of treatment is recommended for any infection, before starting treatment for HIV infection. If the CD4 cell count is around 350, it is recommended that you discuss the treatment of HIV infection with your doctor and start treatment for HIV in Israel as soon as you are ready. Some patients may be advised to begin treatment when their CD4 cell count is still higher than 350, for example, people who have hepatitis B or hepatitis C virus. Another group of people who can start treatment earlier are those with Rh- negative. This is because the treatment of AIDS abroad reduces the viral load and reduces the risk of HIV transmission.

Standard therapy for people starting HIV treatment for the first time is a combination of three drugs. Anti-HIV drugs belong to different classes, depending on their work on HIV. The three main classes of anti-HIV drugs are nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and ritonavir, protease inhibitors. Preferably, the combination of anti-HIV drugs for people taking HIV treatment for the first time is NNRTI efavirenz (Stockrin) or tenofovir NRTI (Viread) and FTC (Emtricitabine, Emtriva) or 3TC (lamivudine, Epivir) and abacavir (Ziagen).

Tenofovir and FTC are combined tablets and are called Truvada. 3TC (lamivudine, Epivir) and abacavir (Ziagen) are part of the Kivex tablet. Before taking Kivex you need to do a blood test to make sure that there is no allergy to abacavir. Kivexa can not be a good choice if u have a risk of heart disease. And tenofovir can not be a good choice if you have kidney problems. If you are taking efavirenz, tenofovir and FTC, as soon as the viral load decreases for at least six months, you can switch and take all three of these drugs in one combination tablet called Atripla.

An alternative to efavirenz, is the protease inhibitor ritonavir. An enhanced protease inhibitor may be a good option if HIV has drug resistance to NNRTIs and NRTIs. Preferred are protease inhibitors lopinavir, atazanavir (Reyataz), darunavir (Presista), fosamprenavir (Telzir) or saquinavir (Invirase). All these protease inhibitors are increased from a single dose of ritonavir, with the exception of lopinavir, which is available only in tablets in combination with ritonavir (Kaletra). The integrase inhibitor raltegravir (Isentress) and inhibitors of the CCR5 receptors maraviroc (Celsentri) has also been approved for people starting HIV treatment abroad.

Women are not recommended to start taking nevirapine if their CD4 cell count exceeds 250 because of the risk of serious side effects. AZT and 3TC (Combivir) are recommended as two other drugs for women planning a pregnancy. These three drugs are recommended during pregnancy, because they have been shown to be a good defense to prevent mother-to-child transmission of VICH.